Have any questions?
+44 1234 567 890
Emotional Journey of Patients with Eosinophilic Esophagitis
Eosinophilic esophagitis (EoE) is a chronic disease with a rising prevalence. Most adult EoE patients experience difficulties eating solid food and therefore they often avoid having meals with friends and family...
Read more … Emotional Journey of Patients with Eosinophilic Esophagitis
Tolerance to sterilised cow's milk in patients with eosinophilic oesophagitis triggered by milk
Cow's milk protein is the main food trigger for eosinophilic oesophagitis (EoE) in children and adults and should be continuously avoided once identified as such...
Fluticasone Propionate Orally Disintegrating Tablet to Treat EoE: Published results from the Phase 2 FLUTE Trial
APT-1011 is an oral disintegrating tablet (ODT) formulation of fluticasone propionate developed by Ellodi/Adare Pharmaceuticals and designed to disintegrate after put on the tongue without water...
Validation of the Swedish Watson Dysphagia Scale for adult patients with eosinophilic esophagitis
The Swedish Watson Dysphagia Scale (S-WDS) has been used to assess dysphagia in patients with eosinophilic esophagitis (EoE) but has not been validated for this patient group...
Non-invasive biomarkers of eosinophilic esophagitis
Eosinophilic gastrointestinal disorders (EGIDs) are emerging inflammatory diseases which may involve any part of the gastrointestinal (GI) tract and lead to the eosinophilic mucosal infiltration in the absence of secondary causes of intestinal eosinophilia...
Read more … Non-invasive biomarkers of eosinophilic esophagitis
Emerging incidence trends of eosinophilic esophagitis over 25 years: Results of a nationwide register-based pathology cohort
De Rooij and coworkers have shown that the incidence of EoE is still ever increasing...
Food-induced immediate response of the esophagus—A newly identified syndrome in patients with eosinophilic esophagitis
This article from a collaborative group of European and American physicians describes a new syndrome, often encountered in overlap with EoE...
Efficacy of proton pump inhibitor therapy for EoE: Results from the CONNECT Registry
PPIs currently constitutes the most commonly used first-line therapy in EoE, mainly due to its safety profile and low cost...
Read more … Efficacy of proton pump inhibitor therapy for EoE: Results from the CONNECT Registry
Psychiatric comorbidity are common in EoE
The prevalence of psychiatric disease in patients with eosinophilic esophagitis (EoE) is not fully characterized...
Practical and clinically useful algorithms for diagnosing and treating EoE
Due to its chronicity, EoE requires both short-term and long-term treatment...
Read more … Practical and clinically useful algorithms for diagnosing and treating EoE
EoE patients more often have food impaction in summer and fall
Eosinophilic esophagitis (EoE) is a chronic inflammatory condition with eosinophilic infiltration of the esophageal mucosa. The most prominent symptom is dysphagia, which may result in esophageal bolus impaction in need of surgical extraction...
Read more … EoE patients more often have food impaction in summer and fall
Conservative treatment of esophageal perforation in patients with eosinophilic esophagitis
There is evidence of an increased fragility in the inflamed esophagus of patients with eosinophilic esophagitis (EoE). We performed a systematic review on presentation, management and outcomes of and surgical interventions for esophageal perforation in these patients.
Adult Patients' Satisfaction with Various Eosinophilic Esophagitis Therapies
The treatment options for eosinophilic esophagitis (EoE) patients include drugs (proton pump inhibitors [PPIs], swallowed topical corticosteroids [STCs]), elimination diets, and dilation. Given the lack of data, we aimed to assess adult EoE patients' satisfaction with different EoE-specific treatment modalities...
Read more … Adult Patients' Satisfaction with Various Eosinophilic Esophagitis Therapies
Efficacy of therapy for eosinophilic esophagitis in real-world practice
Topical steroids, proton pump inhibitors (PPIs), and dietary interventions are recommended first- and second-line therapies for eosinophilic esophagitis (EoE). We investigated differences in their effectiveness in a real-world, clinical practice cohort of patients with EoE...
Read more … Efficacy of therapy for eosinophilic esophagitis in real-world practice
Treatment of eosinophilic esophagitis with diets: an update
Eosinophilic esophagitis (EoE) is a chronic inflammatory esophageal disease triggered and maintained predominantly by food antigens. An elimination diet that avoids the consumption of food triggers currently remains the only therapy targeting the cause of EoE...
Read more … Treatment of eosinophilic esophagitis with diets: an update
Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review
Over the last decade, clinical experiences and research studies raised concerns regarding use of proton pump inhibitors (PPIs) as part of the diagnostic strategy for eosinophilic esophagitis (EoE). We aimed to clarify the use of PPIs in the evaluation and treatment of children and adults with suspected EoE to develop updated international consensus criteria for EoE diagnosis.
Read more … Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review
Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-controlled Trial
Swallowed topical-acting corticosteroids are recommended as first-line therapy for eosinophilic esophagitis (EoE).
Illuminating Elimination Diets: Controversies Regarding Dietary Treatment of Eosinophilic Esophagitis
Eosinophilic esophagitis (EoE) is an immune-mediated disease triggered by food antigens for which dietary elimination treatment can induce and sustain histologic remission.
The frequency of Eosinophilic Esophagitis continues to increase, according to two population-based studies conducted in Spain and the United States
Two recent papers just published in 2018 have documented a dramatic rise in the prevalence of EoE to fect currently more than 1 in 1,000 people.
Helicobacter pylori infection does not protect against EoE: results from a large multicenter case-control study.
Helicobacter pylori (H. pylori) infects approximately 50% of the global population, with a wide variation between regions and countries.